SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Biotechnology

Healthcare
$29.68 +2.49%

+$0.45 today

Market cap
$993.14M
Beta
-0.34
P/E (TTM)
-14.1
EPS (TTM)
-$1.32
52W Low $17.06High $32.44

Volume 0.10M

Average 0.09M

SGP Total Debt

Short-term and long-term borrowings combined.

SpyGlass Pharma, Inc. Common StockNASDAQ: SGP

Total Debt · Q1 FY2026 · quarter ended Mar 2026

Total debt of $1.61M in Q1 FY2026

Q1 FY2026 total debt was $1.61M.

Context

  • Total debt amounted to 0.6% of total assets at the end of Q1 FY2026.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$1.61M+1.6% QoQ
Last fiscal yearDec 2025
$1.58M— YoY
Total Debt past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Total Debt history

USD · from the balance sheet

Latest · FY2025
1.58M USD
Year-over-year change
—

Total Debt vs competitors

How SGP compares with its peers on the latest reported figures

  • Peers report in different currencies, so total debt is compared through growth and share of total assets rather than absolute size.
  • Total debt amounts to 0.6% of total assets for SGP, versus a peer median of 10.8%.
SGP Competitors
Total Debt for SGP and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
ALCAlcon Inc.Sep 2026$5.33B USD+1.8%+1.2%17.0%
BLCOBausch + Lomb CorporationJun 2026$5.12B USD+3.1%+28.1%36.9%
GKOSGlaukos CorporationJun 2026$102.84M USD-2.1%-28.6%11.2%
OCULOcular Therapeutix, Inc.Mar 2026$79.46M USD+4.2%+7.5%10.8%
SGHTSight Sciences, Inc.Mar 2026$41.76M USD+3.2%+5.2%38.1%
STAASTAAR Surgical CompanyApr 2026$37.29M USD+1.7%+7.3%8.3%
EYPTEyePoint Pharmaceuticals, Inc.Mar 2026$20.23M USD-16.0%-23.5%7.0%
RXSTRxSight, Inc.Mar 2026$10.83M USD-10.1%-37.4%3.6%
OCSOculis Holding AGMar 2026CHF 2.24M CHF+103.2%-73.4%0.9%
SGPSpyGlass Pharma, Inc. Common StockMar 2026$1.61M USD——0.6%
Peer median (excluding SGP) —+1.8%+1.2%10.8%

Competitors are the stored peer set for SGP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Intrinsic Alpha fair value

Locked

Current Price

$29.68

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.